---  
layout: startup_page  
title: "Envisagenics"  
id: "envisagenics.com"  
permalink: "/envisagenicsenvisagenics.com06052024/"  
website: "https://www.envisagenics.com"  
funding_round: "Series B"  
funding_amount: ""  
investors: "Third Kind Venture Capital, Empire State Development, Red Cell Partners, Bristol Myers Squibb"  
about: "Envisagenics is an AI-driven biotechnology company focused on discovering and developing novel RNA splicing therapeutics. They utilize their cloud-based AI drug discovery platform, SpliceCore, to identify disease-specific targets for immunotherapies and RNA therapeutics. The company collaborates with biopharmaceutical companies and academic institutions."  
markets: "Biotechnology, AI, Drug Discovery, Oncology, RNA Therapeutics"  
hq: "Long Island City, New York, United States"  
founded_year: "2014"  
linkedin: "https://www.linkedin.com/company/envisagenics"  
twitter: "https://twitter.com/envisagenics"  
instagram: ""  
facebook: "https://www.facebook.com/envisagenicsinc/"  
crunchbase: "https://www.crunchbase.com/organization/envisagenics-inc"  
pitchbook: "https://pitchbook.com/profiles/company/162679-24"  

date_display: "05-Jun-2024"  
date: "2024-06-05"

# SEO Optimization  
meta_title: "Envisagenics - Series B"  
meta_description: "Envisagenics, Envisagenics is an AI-driven biotechnology company focused on discovering and developing novel RNA splicing therapeutics. They utilize their cloud-bas..."  
meta_keywords: "Envisagenics, Biotechnology, AI, Drug Discovery, Oncology, RNA Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/envisagenicsenvisagenics.com06052024/"  
---